- Home
- Companies
- tajikistan
- drug development process
Show results for
Refine by
Drug Development Process Suppliers Serving Tajikistan
37 companies found
based inBaoji City, CHINA
TopTiTech is located in the east area of Baoji High-tech Industrial Development Zone, which is well-known as “Titanium Valley”in China. It is a technology-based private enterprise specializing in the production, research and development and sales of ...
based inHollister, CALIFORNIA (USA)
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across ...
Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inLeiden, NETHERLANDS
A leading pioneer in leveraging iPSC innovation for drug discovery. The catalyst with the requisite iPSC know-how and experience to empower innovators in drug discovery to advance their science relentlessly, consistently and efficiently. For the ...
The discovery that transformed biological research. In 2007, Shinya Yamanaka and Kazutoshi Takahashi were able to reprogram human somatic cells into pluripotent stem cells by inducing the expression of four embryonic transcription factors. The ...
based inYongin, SOUTH KOREA
Bilix is established based on the world’s first PEGylated bilirubin platform technology to produce numerous “First in Class” in anti-inflammatory and “Best in Class” in cancer therapy drugs in addition to achieving other business platform such as ...
based inColumbus, OHIO (USA)
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and ...
Battelle is a global leader in the pharmaceutical and biotechnology (BioPharma) industry by virtue of our integrated scientific and technological capabilities, world-class facilities and the ability to meet the unique technical, development and ...
based inPrinceton, NEW JERSEY (USA)
Freyr is a leading, niche, full-service global Regulatory Solutions and Services Company supporting, Large, Medium and Small size global Life sciences companies, (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer ...
After years of successful clinical research, submission of documents for Health Authority (HA) review requires a specialized skill of clear and precise clinical report writing. Such clear and precise clinical writing aids reviewers to easily ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
based inCambridge, ONTARIO (CANADA)
Advanced Electrophoresis Solutions Ltd. (AES) was founded in 2010. The Company is dedicated in providing cutting-edge instrumentations, ampholytes, and supplies in the iCIEF field. The Company now has become a unique total solution provider for ...
With our ISO:9001 certification, AES is proud to offer a comprehensive range of critical consumables, including proprietary cartridges, ampholytes, pI markers, electrolytes, and general solutions and consumables. In particular, we are ...
based inDurham, NORTH CAROLINA (USA)
Welcome to Patheon. With a commitment to quality, scientific excellence and exceptional customer experiences. Patheon is a leading provider of drug substance and drug product services for the global biopharmaceutical industry. Patheon’s global ...
based inLouisville, KENTUCKY (USA)
Neuroscience researchers throughout the world have used Event Related Potential (ERP) and quantitative electroencephalograph (qEEG) methods to evaluate a wide range of cognitive disorders, including Alzheimer’s disease and concussion/mTBI. ...
COGNISION® is cleared by the FDA. COGNISION® is an objective biomarker system that offers clarity in a field of complexity. By facilitating an objective evaluation of patients with cognitive disorders, COGNISION® helps ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
based inPasadena, VIRGINIA (USA)
Parsons, an engineering, construction, technical, and management services firm with revenues of $3 billion in 2013, is 100% owned by the Employee Stock Ownership Trust. Parsons is a leader in many diversified markets with a focus on transportation, ...
An integrated approach for project success Parsons supports its life sciences customers with commissioning, qualifications, and validation needs by routinely performing validation planning for biotechnology, active pharmaceutical ingredients, dosage ...
based inSolna, SWEDEN
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® ...
Many intravenously delivered Active Pharmaceutical Ingredients (APIs) are insoluble or poorly soluble in water. This can be a major hurdle in pharmaceutical development and may cause promising drugs to fail during ...
based inKraków, POLAND
Ardigen, a world-leading AI CRO, stands at the forefront of enabling AI transformation for the biotech and pharmaceutical sectors. Our objective is to increase the probability of success in the drug development process. We utilize our advanced ...
based inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
In vitro and in vivo methods to provide a study setup that thoroughly determines safety and efficacy. ...
based inNewark, DELAWARE (USA)
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across ...
Macromolecules play an integral role in therapeutic research and development, encompassing therapeutic drugs such as monoclonal antibodies, recombinant proteins, polypeptides, antibody-drug ...
based inWoking, UNITED KINGDOM
IDBS is a leading provider of laboratory informatics and R&D software solutions, designed to accelerate the discovery, development, and manufacturing of therapies. Their offerings include enterprise-grade, cloud-native applications tailored for both ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceutical Solutions specializes in comprehensive drug development services, providing tailored formulation and manufacturing solutions from pre-formulation stages to commercialization. With a focus on overcoming pharmaceutical ...
In the intricate landscape of biopharmaceuticals, development timing is a critical factor that can significantly impact the success or failure of a drug. Saving time can mean the difference between being first to market for a new drug class or a ...
